The present study confirmed that the microprotein N1DARP promotes N1ICD degradation by increasing K11- and K48-linked polyubiquitination of N1ICD, suggesting that N1DARP could be a novel therapeutic target for pancreatic cancer that specifically deactivates the Notch1 pathway. The gene discussed is NOTCH1; the disease is pancreatic neoplasm.